Evidence map›Paper›PMID 29445159›Full record

ArticleCell death & disease2018

Microfluidic cell sorting by stiffness to examine heterogenic responses of cancer cells to chemotherapy.

Muhymin Islam, Roman Mezencev, Brynn McFarland, Hannah Brink, Betsy Campbell, Bushra Tasadduq, Edmund K Waller, Wilbur Lam, Alexander Alexeev, Todd Sulchek

Open access · goldAbstract read
In one paragraph

Article in Cell death & disease, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 73 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. LFC-Lab on a chip · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Methods to mechanically perturb and characterize GUV-based minimal cell models.Computational and structural biotechnology journal · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Muhymin IslamGeorge W. Woodruff School of Mechanical Engineering, Georgia Institute of Technology, 801 Ferst Drive, Atlanta, GA, 30332-0405, USA.
Roman MezencevThe School of Biological Sciences, Georgia Institute of Technology, 310 Ferst Drive, Atlanta, GA, 30332-0535, USA.
Brynn McFarlandWallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology, 313 Ferst Drive, Atlanta, GA, 30332-0535, USA.
Hannah BrinkWallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology, 313 Ferst Drive, Atlanta, GA, 30332-0535, USA.
Betsy CampbellWallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology, 313 Ferst Drive, Atlanta, GA, 30332-0535, USA.
Bushra TasadduqThe School of Electrical and Computer Engineering, Georgia Institute of Technology, 313 Ferst Drive, Atlanta, GA, 30332-0535, USA.
Edmund K WallerWinship Cancer Institute, Emory School of Medicine, 1365 Clifton NE Rd, Atlanta, GA, 30322, USA.
Wilbur LamWallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology, 313 Ferst Drive, Atlanta, GA, 30332-0535, USA.
Alexander AlexeevGeorge W. Woodruff School of Mechanical Engineering, Georgia Institute of Technology, 801 Ferst Drive, Atlanta, GA, 30332-0405, USA.ORCID 0000-0002-8285-0003
Todd SulchekGeorge W. Woodruff School of Mechanical Engineering, Georgia Institute of Technology, 801 Ferst Drive, Atlanta, GA, 30332-0405, USA. todd.sulchek@me.gatech.edu.
Georgia Institute of Technology · USEmory Healthcare · US

Funding

Microfluidic Monitoring of Single Cell Elasticity, Viscoelasticity, and PlasticityR21EB020977 · NIBIB · GEORGIA INSTITUTE OF TECHNOLOGY · PI ALEXEEV, ALEXANDER, LAM, WILBUR A · 2015 to 2016
$405k
NIBIB NIH HHS R21 EB020977
6 · The paper itself

Abstract

Cancers consist of a heterogeneous populations of cells that may respond differently to treatment through drug-resistant sub-populations. The scarcity of these resistant sub-populations makes it challenging to understand how to counter their resistance. We report a label-free microfluidic approach to separate cancer cells treated with chemotherapy into sub-populations enriched in chemoresistant and chemosensitive cells based on the differences in cellular stiffness. The sorting approach enabled analysis of the molecular distinctions between resistant and sensitive cells. Consequently, the role of multiple mechanisms of drug resistance was identified, including decreased sensitivity to apoptosis, enhanced metabolism, and extrusion of drugs, and, for the first time, the role of estrogen receptor in drug resistance of leukemia cells. To validate these findings, several inhibitors for the identified resistance pathways were tested with chemotherapy to increase cytotoxicity sevenfold. Thus, microfluidic sorting can identify molecular mechanisms of drug resistance to examine heterogeneous responses of cancers to therapies.

Indexed as

Gene Expression Regulation, NeoplasticLab-On-A-Chip DevicesAntineoplastic AgentsApoptosisBiomechanical PhenomenaCaffeic AcidsCell SeparationCell SurvivalClarithromycinDaunorubicinDrug CombinationsDrug Resistance, NeoplasmElastic ModulusFulvestrantGene Regulatory NetworksHumansAntineoplastic Agentscaffeic acidCaffeic AcidsClarithromycinDaunorubicinDrug CombinationsFulvestrantKetoconazoleNeoplasm Proteins

Identifiers

PMID29445159
PMCPMC5833447
OpenAlexW2793676899

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.